XS
SM
MD
LG
XL
Regulatory News

Statement re Darktrace

RNS Number : 6855Y
Thoma Bravo LLC
08 September 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE").

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE


8 September 2022

Statement Regarding Darktrace plc ("Darktrace")

Further to the announcement made by Darktrace in relation to a possible offer for Darktrace by Thoma Bravo, L.P. ("Thoma Bravo"), Thoma Bravo confirms that it does not intend to make an offer for Darktrace under Rule 2.7 of the Code.

For the purpose of Rule 2.8 of the Code, Thoma Bravo, and any person(s) acting in concert with it, reserves the right to make or participate in an offer for Darktrace (and/or take any other action which would otherwise be restricted under Rule 2.8 of the Code) within six months of the date of this announcement:

a) with the agreement of the board of Darktrace;

b) following the announcement of a firm intention to make an offer for Darktrace by or on behalf of a third party;

c) following the announcement by Darktrace of a Rule 9 waiver (as referred to in Note 1 of the Notes on Dispensations from Rule 9 of the Code) or for a reverse takeover (as defined in the Code); or

d) where the Panel on Takeovers and Mergers has determined that there has been a material change of circumstances.

Enquiries

Thoma Bravo
Megan Frank
Director, Head of Communications
+1 (212) 731 4778
[email protected]

FGS Global (PR Adviser to Thoma Bravo)
Faeth Birch
+44 (0)20 7251 3801

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OFDFZGGLRNDGZZM